Zhejiang Shengda Bio-Pharm Co., Ltd. announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced sales was CNY 191.930 million compared to CNY 196.538 million a year ago. Operating income was CNY 24.694 million compared to CNY 73.636 million a year ago. Net income was CNY 23.389 million compared to CNY 62.427 million a year ago. Basic earnings per share from continuing operations was CNY 0.14 compared to CNY 0.38 a year ago. Diluted earnings per share from continuing operations was CNY 0.14 compared to CNY 0.35 a year ago.